Thus, Fn can speed up the progression of CMS3 CRC, which is enriched in metabolic pathways involving cholesterol and proteoglycan metabolism and is characterized by an upregulation of inflammatory-related signalling pathways, such as IL-8 signalling or Th17 activation (Ternes et al., 2022). The gene discussed is FN1; the disease is colorectal carcinoma.